EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Navaka Guggulu In the Management of Dyslipidemia (Medoroga): An Evidence-Based Review

Sakshi M. Jatte, Shalinee Kumari Mishra, Kalpesh Dattani

Journal of Ayurveda and Integrated Medical Sciences · 05.05.2026 · 11 (4) · 329-333

DOI: 10.21760/jaims.11.4.48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 05.05.2026. Verfasst von Sakshi M. Jatte und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dyslipidemia is a major metabolic disorder contributing significantly to the rising burden of cardiovascular diseases, particularly in developing countries such as India. Characterized by abnormalities in serum lipid parameters—including elevated total cholesterol, low-density lipoprotein (LDL), triglycerides, and reduced high-density lipoprotein (HDL)—dyslipidemia is closely associated with sedentary lifestyles, unhealthy dietary practices, and metabolic dysfunctions. In Ayurvedic literature, dyslipidemia does not exist as a discrete disease entity; however, it can be conceptually correlated with Medoroga and Medodushti, conditions arising from Agnimandya, Kapha–Meda imbalance, and Santarpana. Conventional hypolipidemic therapies, though effective, are often associated with adverse effects, prompting the exploration of safer, alternative interventions. Navaka Guggulu, a classical polyherbal formulation described in Bhaishajya Ratnavali under Medoroga Chikitsa, possesses Medohara, Lekhana, Deepana, and Amapachana properties. Aim and Objective: to evaluate the role of Navaka Guggulu in the management of dyslipidemia (Medoroga). Materials and Methods: A systematic literature search was conducted across classical Ayurvedic texts and electronic databases including PubMed, Scopus, DHARA, Google Scholar, J-Gate, and Science Direct, focusing on clinical studies evaluating Navaka Guggulu in dyslipidemia, obesity, and related metabolic disorders. Result and Discussion: Navaka Guggulu significantly improves lipid parameters, including reductions in total cholesterol, triglycerides, LDL, and VLDL, with occasional elevation of HDL.

Conclusion

The available clinical evidence supports Navaka Guggulu as an effective and safe Ayurvedic formulation for the management of dyslipidemia and related metabolic disorders. Its multi-targeted actions on lipid metabolism, inflammation, and Ama provide a strong scientific rationale for its indication in Dylipidemia (Medoroga).

Zitieren

APA

Jatte, S. M., Mishra, S. K., & Dattani, K. (2026). Navaka Guggulu In the Management of Dyslipidemia (Medoroga): An Evidence-Based Review. Journal of Ayurveda and Integrated Medical Sciences, 11(4), 329-333. https://doi.org/10.21760/jaims.11.4.48

Vancouver

Jatte SM, Mishra SK, Dattani K. Navaka Guggulu In the Management of Dyslipidemia (Medoroga): An Evidence-Based Review. Journal of Ayurveda and Integrated Medical Sciences. 2026;11(4):329-333. doi:10.21760/jaims.11.4.48

BibTeX
@article{Jatte2026,
  author = {Jatte, Sakshi M. and Mishra, Shalinee Kumari and Dattani, Kalpesh},
  title = {Navaka Guggulu In the Management of Dyslipidemia (Medoroga): An Evidence-Based Review},
  journal = {Journal of Ayurveda and Integrated Medical Sciences},
  year = {2026},
  volume = {11},
  number = {4},
  pages = {329--333},
  doi = {10.21760/jaims.11.4.48}
}
Kostenlos starten →